Drug intelligence / Profile preview

Phytosoya

Development stage
Unknown
Lead developer
Arkopharma
Modality
Small Molecules
Administration
Oral
01

Overview

Phytosoya is a standardized soy isoflavone extract developed by Laboratoires Arkopharma, specifically formulated to manage symptoms associated with climacteric syndrome (menopause). The product contains a specific profile of isoflavones, primarily genistein and daidzein, which are naturally occurring phytoestrogens. These compounds function as selective estrogen receptor modulators (SERMs), exhibiting a higher binding affinity for estrogen receptor beta (ER-beta) compared to estrogen receptor alpha (ER-alpha). By mimicking the effects of estrogen in a tissue-selective manner, Phytosoya helps reduce the frequency and intensity of hot flashes and other vasomotor symptoms. Clinical research, including long-term safety studies, has demonstrated that the 70 mg daily dose of this specific extract does not significantly increase endometrial thickness or breast density in postmenopausal women, addressing common safety concerns associated with hormone replacement therapies.

Brand names
Phytosoya
Other names
soy isoflavone extractstandardized soy isoflavone extractArkopharma soy isoflavones
02

Targets

ESR2 (ERβ)ESR1 (ERα)

Beyond the preview

Go deeper on Phytosoya.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phytosoya.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call